Back to GetFilings.com



Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 10-Q

     
[X]   Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
     
    For the period ended August 31, 2003.
     
[  ]   Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
     
    For the transition period from to
     
    Commission File Number    1-9927

COMPREHENSIVE CARE CORPORATION

(Exact name of registrant as specified in its charter)
     
Delaware   95-2594724

 
(State or other jurisdiction of incorporation
or organization)
  (IRS Employer Identification No.)

200 South Hoover Blvd, Suite 200, Tampa, FL 33609


(Address of principal executive offices and zip code)

(813) 288-4808


(Registrant’s telephone number, including area code)

     Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes [X] No [  ]

     Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).

Yes [  ] No [X]

     Indicate the number of shares outstanding of each of the issuer’s classes of Common Stock, as of the latest practicable date:

     
Classes   Outstanding at October 6, 2003

 
Common Stock, par value $.01 per share   3,939,549

 


TABLE OF CONTENTS

PART I. — FINANCIAL INFORMATION
Item 1 — Consolidated Financial Statements
Consolidated Balance Sheets
Consolidated Statements of Operations
Consolidated Statements of Cash Flows
Item 2 — Management’s discussion and analysis of financial condition and Results of operations
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Item 4. Controls and Procedures
PART II — OTHER INFORMATION
Item 1 — LEGAL PROCEEDINGS
Item 6 — Exhibits and Reports on Form 8-K
SIGNATURES
Ex.31.1 Section 302 Certification of CEO
Ex.31.2 Section 302 Certification of CFO
Ex.32.1 Section 906 Certification of CEO
Ex.32.2 Section 906 Certification of CFO


Table of Contents

COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES

Index

               
          Page
PART I – FINANCIAL INFORMATION
       
   
Item 1—Consolidated Financial Statements
       
     
    Consolidated Balance Sheets, August 31, 2003 and May 31, 2003
    3  
     
    Consolidated Statements of Operations for the three months ended August 31, 2003 and 2002
    4  
     
    Consolidated Statements of Cash Flows for the three months ended August 31, 2003 and 2002
    5  
     
    Notes to Consolidated Financial Statements
    6-11  
   
Item 2—Management’s Discussion and Analysis of Financial Condition and Results of Operations
    11-17  
   
Item 3—Quantitative and Qualitative Disclosures About Market Risk
    17  
   
Item 4—Controls and Procedures
    17-18  
PART II – OTHER INFORMATION
       
   
Item 1—Legal Proceedings
    18  
   
Item 6—Exhibits and Reports on Form 8-K
    19  
   
Signatures
    20  
   
Certifications
    21-24  

2


Table of Contents

COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES

PART I. – FINANCIAL INFORMATION

Item 1 — Consolidated Financial Statements

Consolidated Balance Sheets

                   
      August 31,   May 31,
      2003   2003
     
 
      (unaudited)        
      (Amounts in thousands)
ASSETS
               
Current assets:
               
 
Cash and cash equivalents
  $ 3,416     $ 3,590  
 
Accounts receivable, less allowance for doubtful accounts of $27
    257       75  
 
Accounts receivable – managed care reinsurance contract
    485       354  
 
Other current assets
    445       605  
 
   
     
 
Total current assets
    4,603       4,624  
Property and equipment, net
    284       230  
Note receivable
    154       155  
Goodwill, net
    991       991  
Restricted cash
    327       328  
Other assets
    46       51  
 
   
     
 
Total assets
  $ 6,405     $ 6,379  
 
   
     
 
LIABILITIES AND STOCKHOLDERS’ DEFICIT
               
Current liabilities:
               
 
Accounts payable and accrued liabilities
  $ 2,001     $ 1,836  
 
Accrued claims payable
    4,039       4,103  
 
Accrued reinsurance claims payable
    3,343       3,117  
 
Income taxes payable
    17       15  
 
   
     
 
Total current liabilities
    9,400       9,071  
 
   
     
 
Long-term liabilities:
               
 
Long-term debt
    2,244       2,244  
 
Other liabilities
    58       54  
 
   
     
 
Total long-term liabilities
    2,302       2,298  
 
   
     
 
Total liabilities
    11,702       11,369  
 
   
     
 
Commitments and Contingencies (Note 5)
               
Stockholders’ deficit:
               
 
Preferred stock, $50.00 par value; authorized 18,740 shares; none issued
           
 
Common stock, $0.01 par value; authorized 12,500,000 shares; issued and outstanding 3,939,049 and 3,936,549
    39       39  
 
Additional paid-in-capital
    51,940       51,928  
 
Deferred compensation
    (10 )     (16 )
 
Accumulated deficit
    (57,266 )     (56,941 )
 
   
     
 
Total stockholders’ deficit
    (5,297 )     (4,990 )
 
   
     
 
Total liabilities and stockholders’ deficit
  $ 6,405     $ 6,379  
 
   
     
 

See accompanying notes.

3


Table of Contents

COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES

Consolidated Statements of Operations
(Unaudited)
(Amounts in thousands, except per share amounts)

                   
      Three months Ended
      August 31,
     
      2003   2002
     
 
Operating revenues
  $ 7,893     $ 8,307  
Costs and expenses:
               
 
Healthcare operating expenses
    6,852       7,353  
 
General and administrative expenses
    908       888  
 
Recovery of doubtful accounts
    (8 )     (8 )
 
Depreciation and amortization
    27       68  
 
   
     
 
 
    7,779       8,301  
 
   
     
 
Operating income from continuing operations before items shown below
    114       6  
Other income (expense):
               
 
Gain on sale of assets
          3  
 
Loss on disposal of assets
          (5 )
 
Interest income
    12       16  
 
Interest expense
    (48 )     (46 )
 
Other non-operating income
    1        
 
   
     
 
Income (loss) from continuing operations before income taxes
    79       (26 )
Income tax expense
    17       7  
 
   
     
 
Income (loss) from continuing operations
  $ 62     $ (33 )
Loss from Discontinued Operations
    (387 )      
 
   
     
 
Net loss attributable to common stockholders
  $ (325 )   $ (33 )
 
   
     
 
Earnings (loss) per common share — basic:
               
Earnings (loss) from continuing operations
  $ 0.02     $ (0.01 )
Loss from discontinued operations
    (0.10 )      
 
   
     
 
Net loss
  $ (0.08 )   $ (0.01 )
 
   
     
 
Earnings (loss) per common share — diluted:
               
Earnings (loss) from continuing operations
  $ 0.01     $ (0.01 )
Loss from discontinued operations
    (0.08 )      
 
   
     
 
Net loss
  $ (0.07 )   $ (0.01 )
 
   
     
 
Weighted average common shares outstanding:
               
Basic
    3,937       3,885  
 
   
     
 
Diluted
    4,725       3,885  
 
   
     
 

See accompanying notes.

4


Table of Contents

COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES

Consolidated Statements of Cash Flows
(Unaudited)

                   
      Three months ended
      August 31,
     
      2003   2002
     
 
      (Amounts in thousands)
Cash flows from operating activities:
               
Net income (loss) from continuing operations
  $ 62     $ (33 )
Adjustments to reconcile net income (loss) to net cash used in operating activities:
               
 
Depreciation and amortization
    27       68  
 
Compensation expense — stock and stock options issued
    17       11  
 
Gain on sale of assets
          (3 )
 
Loss on disposal of assets
          5  
Changes in assets and liabilities:
               
 
Accounts receivable
    (182 )     (6 )
 
Accounts receivable — managed care reinsurance contract
    (131 )     (101 )
 
Other current assets, restricted funds, and other non-current assets
    74       (92 )
 
Accounts payable and accrued liabilities
    (121 )     (433 )
 
Accrued claims payable
    (64 )     (970 )
 
Accrued reinsurance claims payable
    226       402  
 
Income taxes payable
    2       4  
 
Other liabilities
          (2 )
 
   
     
 
 
Net cash used in continuing operations
    (90 )     (1,150 )
 
Net cash used in discontinued operations
           
 
   
     
 
 
Net cash used in continuing and discontinued operations
    (90 )     (1,150 )
 
   
     
 
Cash flows from investing activities:
               
 
Net proceeds from sale of property and equipment
          2  
 
Payments received on note receivable
    1       1  
 
Additions to property and equipment
    (80 )     (18 )
 
   
     
 
 
Net cash used in investing activities
    (79 )     (15 )
 
   
     
 
Cash flows from financing activities:
               
 
Proceeds from issuance of Common Stock
    1        
 
Repayment of debt
    (6 )     (1 )
 
   
     
 
 
Net cash used in financing activities
    (5 )     (1 )
 
   
     
 
Net decrease in cash and cash equivalents
    (174 )     (1,166 )
Cash and cash equivalents at beginning of year
    3,590       5,340  
 
   
     
 
Cash and cash equivalents at end of period
  $ 3,416     $ 4,174  
 
   
     
 

See accompanying notes

5


Table of Contents

COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES

Note 1 – Summary of Significant Accounting Policies

     The consolidated balance sheet as of August 31, 2003, and the related consolidated statements of operations and cash flows for the three months ended August 31, 2003 and 2002 are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. In the opinion of management, all adjustments necessary for a fair presentation of such financial statements have been included. Such adjustments consisted only of normal recurring items. The results of operations for the three months ended August 31, 2003 are not necessarily indicative of the results to be expected during the balance of the fiscal year.

     The consolidated financial statements do not include all information and footnotes necessary for a complete presentation of financial position, results of operations and cash flows in conformity with accounting principles generally accepted in the United States of America. The balance sheet at May 31, 2003 has been derived from the audited financial statements at that date, but does not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statement presentation. Notes to consolidated financial statements included in Form 10-K for the year ended May 31, 2003 are on file with the Securities and Exchange Commission and provide additional disclosures and a further description of accounting policies.

     The Company’s financial statements are presented on the basis that it is a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The consolidated financial statements do not include any adjustments to reflect the possible future effects on the recovery and classification of assets or the amount and classification of liabilities that may result from the outcome of the uncertainties described in Note 2 — “Basis of Presentation.”

     The Company’s managed care activities are performed under the terms of agreements with health maintenance organizations (“HMOs”), preferred provider organizations (“PPOs”), and other health plans or payers to provide contracted behavioral healthcare services to subscribing participants. Revenue under a substantial portion of these agreements is earned monthly based on the number of qualified participants regardless of services actually provided (generally referred to as capitation arrangements). Such agreements accounted for 87.7%, or $6.9 million, of revenue for the three months ended August 31, 2003 and 86.6%, or $7.2 million, of revenue for the three months ended August 31, 2002. The balance of the Company’s revenues is earned on a fee-for-service basis and is recognized as services are rendered.

Restricted Cash

     As of August 31, 2003 and May 31, 2003, non-current restricted accounts include $0.3 million of cash held in trust in connection with the Company’s Directors and Officers liability insurance policy.

Accrued Claims Payable

     The accrued claims payable liability represents the estimated ultimate net amounts owed for all behavioral healthcare services provided through the respective balance sheet dates, including estimated amounts for claims incurred but not yet reported (“IBNR”) to the Company. The unpaid claims liability is estimated using an actuarial paid completion factor methodology and other statistical analyses and is continually reviewed and adjusted, if necessary, to reflect any change in the estimated liability. These estimates are subject to the effects of trends in utilization and other factors. However, actual claims incurred could differ from the estimated claims payable amount reported as of August 31, 2003. Although considerable variability is inherent in such estimates, management believes that the unpaid claims liability is adequate.

Income Taxes

     The Company calculates deferred taxes and related income tax expense using the liability method. This method determines deferred taxes by applying the current tax rate to net operating loss carryforwards and to the cumulative temporary differences between the recorded carrying amounts and the corresponding tax basis of assets and liabilities. A valuation allowance is established for deferred tax assets unless their realization is considered more likely than not. The Company’s provision for income taxes is the sum of the change in the balance of deferred taxes between the beginning and the end of the period and income taxes currently payable or receivable.

6


Table of Contents

COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES

Stock Options

     In December 2002, the Financial Accounting Standards Board issued Statements of Financial Accounting Standards No. 148, “Accounting for Stock-Based Compensation – Transition and Disclosure,” which amends the disclosure requirements of SFAS 123, “Accounting for Stock-Based Compensation” and provides alternative methods of transition for a voluntary change to the fair value method of accounting for stock-based employee compensation. As permitted by SFAS 148, the Company has elected to follow Accounting Principles Board Opinion No. 25, “Accounting for Stock Issued to Employees” (APB 25) and related interpretations in accounting for its employee stock options. Under APB 25, in the event that the exercise price of the Company’s employee stock options is less than the market price of the underlying stock on the date of grant, compensation expense is recognized. No stock-based employee compensation cost is reflected in net income, as all options granted under the Company’s employee stock options plans had an exercise price equal to the market value of the underlying common stock on the date of grant. The following table illustrates the effect on net loss and loss per share if the Company had applied the fair value recognition provisions of SFAS No. 123 to stock-based employee compensation.

                     
        Quarter Ended August 31,
       
        2003   2002
       
 
        (in thousands except for
        per share information)
       
Net loss, as reported
  $ (325 )   $ (33 )
Deduct:
               
   
Total stock-based employee compensation expense determined under fair value based method for all awards, net of related tax effects
    (40 )     (9 )
 
   
     
 
Pro forma net loss
  $ (365 )   $ (42 )
 
   
     
 
Loss per common share:
               
 
Basic – as reported
  $ (0.08 )   $ (0.01 )
 
   
     
 
 
Diluted – as reported
  $ (0.07 )   $ (0.01 )
 
   
     
 
 
Basic – pro forma
  $ (0.09 )   $ (0.01 )
 
   
     
 
 
Diluted – pro forma
  $ (0.08 )   $ (0.01 )
 
   
     
 

7


Table of Contents

COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES

Per Share data

     In calculating basic earnings (loss) per share, net income (loss) is divided by the weighted average number of common shares outstanding for the period. Diluted earnings per share reflect the assumed exercise or conversion of all dilutive securities, such as options, warrants, and convertible debentures. No such exercise or conversion is assumed where the effect is antidilutive, such as when there is a net loss. The following table sets forth the computation of basic and diluted earnings (loss) per share in accordance with Statement No. 128, Earnings Per Share (amounts in thousands, except per share data):

                     
        Three Months Ended
        August 31,
       
        2003   2002
       
 
Numerator:
               
 
Numerator for diluted earnings (loss) per share from continuing operations
  $ 62     $ (33 )
 
Loss from discontinued operations
    (387 )      
 
   
     
 
 
Net loss attributable to common stockholders
  $ (325 )   $ (33 )
 
   
     
 
Denominator:
               
   
Weighted average shares
    3,937       3,885  
   
Effect of dilutive securities:
               
   
Employee stock options
    782        
   
Warrants
    6        
 
   
     
 
   
Denominator for diluted earnings (loss) per share-adjusted weighted average shares after assumed conversions
    4,725       3,885  
 
   
     
 
Basic loss per share:
               
 
Income (loss) from continuing operations
  $ 0.02     $ (0.01 )
 
Loss from discontinued operations
    (0.10 )      
 
   
     
 
 
Net loss
  $ (0.08 )   $ (0.01 )
 
   
     
 
Diluted loss per share:
               
 
Income (loss) from continuing operations
  $ 0.01     $ (0.01 )
 
Loss from discontinued operations
    (0.08 )      
 
   
     
 
 
Net loss
  $ (0.07 )   $ (0.01 )
 
   
     
 

Authorized shares of common stock reserved for possible issuance for convertible debentures and stock options are as follows at August 31, 2003:

         
Convertible debentures
    9,044  
Outstanding stock options
    1,105,724  
Possible future issuance under stock option plans
    445,235